Suchergebnisse - "YO603Y8113"

PubPharm (668)

1

Simplification of ART in a patient living with multidrug resistant HIV-1 : A case report using twice daily cobicistat and darunavir

enthalten in: International journal of STD & AIDS | 2019

von Brizzi, M. | Novak, R. | Chiampas, T.

2

Similar plasma lipidomic profile in people living with HIV treated with a darunavir-based or an integrase inhibitor-based antiretroviral therapy

enthalten in: Scientific reports | 2019

von Mena, A. | Clavero, E. | Díaz-Díaz, J. | +1

3

Evaluation of kidney function in HIV-infected patients receiving an antiretroviral regimen containing one or two inhibitors of the tubular secretion of creatinine

enthalten in: HIV medicine | 2019

von Casado, J. | Monsalvo, M. | Vizcarra, P. | +3

4

Picomolar to Micromolar : Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance

enthalten in: ACS chemical biology | 2019

von Henes, M. | Lockbaum, G. | Kosovrasti, K. | +10

5

Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing : a prospective cohort study

enthalten in: The lancet. HIV | 2019

von Eholie, S. | Moh, R. | Benalycherif, A. | +28

CommentIn: Lancet HIV. 2019 Nov;6(11):e725-e727. - PMID 31601545

6

Determinants of blood telomere length in antiretroviral treatment-naïve HIV-positive participants enrolled in the NEAT 001/ANRS 143 clinical trial

enthalten in: HIV medicine | 2019

von Alejos, B. | Stella-Ascariz, N. | Montejano, R. | +13

7

Use of darunavir in HIV-1-infected individuals in routine clinical practice from 2012 to 2016 in France

enthalten in: The Journal of antimicrobial chemotherapy | 2019

von Potard, V. | Canestri, A. | Gallien, S. | +53

8

The HIV protease inhibitor darunavir prevents kidney injury via HIV-independent mechanisms

enthalten in: Scientific reports | 2019

von Gao, X. | Rosales, A. | Karttunen, H. | +7

ErratumIn: Sci Rep. 2020 Mar 4;10(1):4345. - PMID 32132565

9

Dolutegravir with boosted darunavir as treatment simplification for treatment-experienced HIV patients with multiple mutations

enthalten in: International journal of STD & AIDS | 2019

von Paparizos, V. | Vasalou, V. | Kourkounti, S.

10

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1

enthalten in: Antiviral research | 2019

von Eron, J. | Orkin, C. | Cunningham, D. | +111

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[67]